RIZATRIPTAN BENZOATE vs RIZATRIPTAN BENZOATE ODT

Compare RIZATRIPTAN BENZOATE (MAXALT) and RIZATRIPTAN BENZOATE ODT (Rizatriptan Benzoate ODT) — clinical data, side effects, and patient experiences.

RIZATRIPTAN BENZOATE

MAXALT, MAXALT-MLT · Triptan (Migraine)

How it works

12.1 Mechanism of Action Rizatriptan binds with high affinity to human cloned 5-HT 1B/1D receptors. MAXALT presumably exerts its therapeutic effects in the treatment of migraine he...

Approved for

See full prescribing information

OralTablet

RIZATRIPTAN BENZOATE ODT

Rizatriptan Benzoate ODT · Triptan (Migraine)

How it works

Other agent

Approved for

See full prescribing information

OralTablet

Quick Comparison

RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATE ODT

Drug Class

Triptan (Migraine)

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

RIZATRIPTAN BENZOATE

Drug Not Working

>10%

Nausea

>10%

Headache

>10%

Fatigue

1-10%

Vomiting

1-10%

Dizziness

0.1-1%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

RIZATRIPTAN BENZOATE ODT

Vomiting

1-10%

Dizziness

0.1-1%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

Joint Pain

0.1-1%

Anxiety

0.1-1%

Excessive Sweating

0.1-1%

Drug Not Working

>10%

FDA Warnings

RIZATRIPTAN BENZOATE

5 WARNINGS AND PRECAUTIONS Myocardial ischemia, myocardial infarction, and Prinzmetal's angina: Perform cardiac evaluation in patients with multiple cardiovascular risk factors ( 5
2 ) Chest/throat/neck/jaw pain, tightness, pressure, or heaviness; Generally not associated with myocardial ischemia; Evaluate patients at high risk ( 5
There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration of MAXALT
Triptan-naïve patients who have multiple cardiovascular risk factors (e

RIZATRIPTAN BENZOATE ODT

There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration of rizatriptan benzoate
Triptan-naïve patients who have multiple cardiovascular risk factors (e
Periodic cardiovascular evaluation should be considered in intermittent long-term users of rizatriptan benzoate who have cardiovascular risk factors
2 Arrhythmias Life-threatening disturbances of cardiac rhythm, including ventricular tachycardia and ventricular fibrillation leading to death, have been reported within a few hours following the administration of 5-HT1 agonists

Clinical Trial Data

No head-to-head clinical studies found for RIZATRIPTAN BENZOATE vs RIZATRIPTAN BENZOATE ODT.

RIZATRIPTAN BENZOATE vs RIZATRIPTAN BENZOATE ODT: What You Should Know

Key Differences

Both RIZATRIPTAN BENZOATE and RIZATRIPTAN BENZOATE ODT belong to the Triptan (Migraine) class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Shared Indications

Both medications are approved for See full prescribing information. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.

Safety Considerations

RIZATRIPTAN BENZOATE carries 4 FDA warnings. RIZATRIPTAN BENZOATE ODT carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

FROVATRIPTAN SUCCINATE vs RIZATRIPTAN BENZOATE ODT→FROVATRIPTAN SUCCINATE vs RIZATRIPTAN BENZOATE→ELETRIPTAN HBR vs RIZATRIPTAN BENZOATE ODT→ELETRIPTAN HBR vs RIZATRIPTAN BENZOATE→RIZATRIPTAN BENZOATE ODT vs SUMATRIPTAN SUCCINATE→RIZATRIPTAN BENZOATE vs SUMATRIPTAN SUCCINATE→

Loading comparison data...

RIZATRIPTAN BENZOATE vs RIZATRIPTAN BENZOATE ODT

Compare RIZATRIPTAN BENZOATE (MAXALT) and RIZATRIPTAN BENZOATE ODT (Rizatriptan Benzoate ODT) — clinical data, side effects, and patient experiences.

RIZATRIPTAN BENZOATE

MAXALT, MAXALT-MLT · Triptan (Migraine)

How it works

12.1 Mechanism of Action Rizatriptan binds with high affinity to human cloned 5-HT 1B/1D receptors. MAXALT presumably exerts its therapeutic effects in the treatment of migraine he...

Approved for

See full prescribing information

OralTablet

RIZATRIPTAN BENZOATE ODT

Rizatriptan Benzoate ODT · Triptan (Migraine)

How it works

Other agent

Approved for

See full prescribing information

OralTablet

Quick Comparison

RIZATRIPTAN BENZOATERIZATRIPTAN BENZOATE ODT

Drug Class

Triptan (Migraine)

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

RIZATRIPTAN BENZOATE

Drug Not Working

>10%

Nausea

>10%

Headache

>10%

Fatigue

1-10%

Vomiting

1-10%

Dizziness

0.1-1%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

RIZATRIPTAN BENZOATE ODT

Vomiting

1-10%

Dizziness

0.1-1%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

Joint Pain

0.1-1%

Anxiety

0.1-1%

Excessive Sweating

0.1-1%

Drug Not Working

>10%

FDA Warnings

RIZATRIPTAN BENZOATE

5 WARNINGS AND PRECAUTIONS Myocardial ischemia, myocardial infarction, and Prinzmetal's angina: Perform cardiac evaluation in patients with multiple cardiovascular risk factors ( 5
2 ) Chest/throat/neck/jaw pain, tightness, pressure, or heaviness; Generally not associated with myocardial ischemia; Evaluate patients at high risk ( 5
There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration of MAXALT
Triptan-naïve patients who have multiple cardiovascular risk factors (e

RIZATRIPTAN BENZOATE ODT

There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration of rizatriptan benzoate
Triptan-naïve patients who have multiple cardiovascular risk factors (e
Periodic cardiovascular evaluation should be considered in intermittent long-term users of rizatriptan benzoate who have cardiovascular risk factors
2 Arrhythmias Life-threatening disturbances of cardiac rhythm, including ventricular tachycardia and ventricular fibrillation leading to death, have been reported within a few hours following the administration of 5-HT1 agonists

Clinical Trial Data

No head-to-head clinical studies found for RIZATRIPTAN BENZOATE vs RIZATRIPTAN BENZOATE ODT.

RIZATRIPTAN BENZOATE vs RIZATRIPTAN BENZOATE ODT: What You Should Know

Key Differences

Shared Indications

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.